Comment on article: “Diagnostic rentability of close pleural biopsy: Tru-cut vs. Cope

René Agustín Flores-Franco; Ernesto Ramos-Martínez

2019, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2019; 57 (1)

Comment on article: “Diagnostic rentability of close pleural biopsy: Tru-cut vs. Cope

Flores-Franco RA, Ramos-Martínez E

Full text

How to cite this article

Language: Spanish
References: 2
Page: 6
PDF size: 271.10 Kb.

Text Extraction

In this letter to the editor it is discussed the use of Trucut needle in pleural biopsy and its profitability for the diagnosis of mesothelioma; it is exposed as well its usefulness, having the appropriate training, to obtain guiding results in obese people.

REFERENCES

Valdez-López HG, Cano-Rodríguez AI, Montemayor-Chapa M, Castillo Sánchez JF. Rentabilidad diagnóstica de la biopsia pleural cerrada: Tru-cut frente a Cope. Rev Med Inst Mex Seguro Soc. 2018;56(1):12-7.
Flores-Franco RA, Ramos-Martínez E, Luévano-Flores E, Fierro-Murga R, Barriga-Acevedo R, Martínez-Tapia ME et al. Malignant mesothelioma trends in Chihuahua, Mexico. Salud Publica Mex. 2014;56(4):315-6.